Ortho-tag & University of Pittsburgh Enter Into a Global Licensing Agreement of Transcutaneous Near Field Communication Technology

Ortho-tag signed a global licensing agreement with the University of Pittsburgh to utilize Transcutaneous Near Field Communication (TNFC) technology in “smart” medical devices for orthopaedic implants and recipient patients. Ortho-tag and the University of Pittsburgh’s Swanson School of Engineering entered into an agreement for the ongoing research for future Ortho-tag technologies and products.

TNFC is a critical component of the Ortho-tag stable of products which enables the transcutaneous transmission of information between the patented Orthotag affixed to an orthopaedic implant and a proprietary Ortho-tag Touch Probe/Reader. As part of an all-inclusive system, the Orthotag enables orthopaedic surgeons to easily identify vital information about a patient’s implant. Included in the technology is an Ortho-tag Card which is designed for all previous implant patients, as well as future ones. The Ortho-tag Card gives patients the ability to have with them, at all times, pertinent information related to their implant and implant surgery.

Source: Ortho-Tag, Inc.

RELATED ARTICLES



CONTACT BONEZONE

 

CONTACT BONEZONE